{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-028403","form_type":"8-K","ticker":"JAGX","cik":"0001585608","company_name":"Jaguar Health, Inc.","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.086987+00:00","generated_at":"2026-05-26T01:49:07.177318+00:00","sec_items":["1.01","3.03","5.03","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Jaguar Health adopts 1-year rights plan after receiving acquisition interest","bullets":["Board adopted limited-duration rights plan on Feb 26, 2025; expires Feb 26, 2026.","Rights trigger at 20% beneficial ownership of voting stock; holders can buy shares at $4.50 for twice the market value.","Jaguar received indication of interest to acquire the company; plan aims to discourage open-market accumulation without a premium.","First proof-of-concept IIT results for crofelemer in SBS-IF and MVID expected Q2 2025; FDA meeting on breast cancer subgroup results also Q2.","Record date for rights dividend is March 10, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-028403","json":"https://secwatch.observer/filing/0000950170-25-028403.json","markdown":"https://secwatch.observer/filing/0000950170-25-028403.md","text":"https://secwatch.observer/filing/0000950170-25-028403.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000095017025028403/0000950170-25-028403-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000095017025028403/jagx-20250226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T01:49:07.177318+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}